Filing Details

Accession Number:
0001225208-14-024549
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-12-08 18:55:25
Reporting Period:
2014-12-08
Filing Date:
2014-12-08
Accepted Time:
2014-12-08 18:55:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
310158 Merck & Co. Inc. MRK Pharmaceutical Preparations (2834) 221918501
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1408181 N Bruce Kuhlik 2000 Galloping Hill Road
Kenilworth NJ 07033
Exe V-P & Gen Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-12-08 50,000 $51.02 178,467 No 4 M Direct
Common Stock Disposition 2014-12-08 50,000 $62.00 128,467 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2014-12-08 50,000 $0.00 50,000 $51.02
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2008-08-01 2017-07-31 No 4 M Direct
Footnotes
  1. The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
  2. Holdings include shares acquired in dividend reinvestment transactions.
  3. The option became exercisable in equal installments on 8/1/2008, 8/1/2009 and 8/1/2010.